检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:肖蕾[1] 蒋戈利[1] 赵建国[2] 王立新[3] 邢军[1] 李坚将[1] 杨政霞[1]
机构地区:[1]中国人民解放军第464医院中医针灸中心,天津300381 [2]天津中医学院第一附属医院,天津300193 [3]中国人民解放军第254医院,天津300142
出 处:《中国中医药信息杂志》2007年第1期23-25,共3页Chinese Journal of Information on Traditional Chinese Medicine
基 金:国家中医药管理局立项资助课题(03XDLZ45)
摘 要:目的寻找治疗感冒高热的有效针灸疗法。方法按照随机化和多中心临床试验原则,将列入统计病例276例随机分为治疗组(138例)和对照组(138例)。治疗组采用电针大椎穴,对照组采用安痛定注射液,2组均配合病因治疗,观察治疗后24h的即时疗效。结果治疗组治疗后各时点体温均低于对照组(P<0.01);治疗组治疗后相关症状积分在3~24h低于对照组(P<0.05)。治疗组痊愈率为33.8%,有效率为98.5%;对照组痊愈率为14.1%,有效率为92.2%。2组比较差异均有显著性意义(P<0.05),治疗组痊愈率、有效率均优于对照组。不同对症治疗对2组综合疗效的影响差异无显著性意义(P>0.05)。结论电针大椎穴配合病因治疗感冒高热疗效确切。Objective To search for an effective acupuncture-moxibustion therapy for high fever in common cold. Methods According to the randomized and multi-central trial principle, 276 cases enrolled were randomly assigned to observation group of 138 casesand control group of 138 cases. The observation group were treated by electroacupuncture at Dazhui and the control group were treated by Antondinie injection coordinating pathogeny therapy to observe the prompt effects in 24 hours. After treatment, the temperature of every time point of the observation group was lower than that of the control group (P〈0.01) and the related symptom value of the observation group were lower than that of the control group in 3-24h (P〈0.05). The cure rate and the effective rate were 33.8% and 98.5% in the observation group, and 14.1% and 92.2% in the control group, with significant differences between the two groups, the observation group being better than the control group (P〈0.05). The different corresponding treatment has no significant difference in the therapeutic effect between the two groups (P〉0.05). The method of electroacupuncturing at Dazhui has a definite therapeutic effect on high fever in common cold.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3